Skip to main content

CCTG Connection



Published:
Category: Publications
Publication: General Review
A series of general review publications 1. Combination of alpha-lipoic acid and pregabalin for neuropathic pain 2. Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC 3. Scalable inference for individual treatment effect 4. A nonlinear accelerated failure time model with artificial neural network Read More

Published:
Category: Publications
ASCO GI Abstracts
CCTG related research presented at the ASCO GI Cancer Symposium, January 23-25, 2025 in San Francisco.
 
CO28
Loree JM, Titmuss E, Brown CJ, Rich TA, Tu D, Jonker DJ, O'Callaghan CJ, Kennecke HF. Tumour-free ctDNA detection as a decision tool to support organ preservation in node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II NEO trial (CCTG CO.28). ASCO Gastrointestinal Cancer Symposium.
Read More

Published:
Category: Publications
Publication: IND242A substudy

A phase II study of neoadjuvant opnurasib KRAS G12C inhibitor in patients with surgically resectable non-small cell lung cancer: A substudy of the IND.242 platform master protocol

Read More



Published:
Category: Group updates
departing patient representatives Marie-Térèse Little and Carol Gordon

The CCTG Patient Representative Committee (PRC) sends a heartfelt thank you to two key members who will be leaving us this month, Marie-Térèse Little and Carol Gordon. Their contributions have been transformative, and we are fortunate to have had their unwavering engagement and insight over the years. Their dedication will continue to inspire and elevate the work of the committee to improve cancer research for patients everywhere.

Read More

Published:
Category: Group updates
The CCTG Annual Spring Meeting

The CCTG Annual Spring Meeting is only 5 weeks away! If you have not registered or requested an Invitation, please do so now! Here are some things for you to keep in mind:

Meeting Information

All meeting information is available on the Spring Meeting Web Page and includes:

Read More

Published:
Category: News
CAN-PACT - Building a Research, Practice and Policy Foundation

A new national initiative as been funded by the Canadian Cancer Society, through their Breakthrough Team Grant competition. The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT), is bringing together researchers, clinicians, policymakers, and people living with advanced cancer to explore the potential of psychedelic-assisted therapy as a transformative approach to cancer care.

Read More

Published:
Category: Publications
Publication: LYC1, REC4, CE8
Primary publications for LYC1: Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL, and REC4: Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy and CE8: Marizomib for patients with newly diagnosed glioblastoma. Read More

Published:
Category: Publications
Publication: PA6, CE6, CLC2, CRC6, CO17
A series of publication in relation to CCTG trials comprising secondary analysis, updated analysis and nested cohort. Read More